Mehran Score for Post-PCI Contrast Nephropathy

Estimates the risk of contrast‑induced nephropathy after PCI based on clinical and procedural factors.

Hypotension
No0Yes+5
Intra-aortic balloon pump
No0Yes+5
CHF
No0Yes+5
Age > 75 years
No0Yes+4
Anemia
No0Yes+3
Diabetes
No0Yes+3
Contrast media volume
0 mL0100 mL+1200 mL+2300 mL+3400 mL+4500 mL+5600 mL+6700 mL+7800 mL+8900 mL+91000 mL+101100 mL+111200 mL+121300 mL+131400 mL+141500 mL+15
eGFR, mL/min/1.73m^2
≥ 60040 to < 60+220 to < 40+4< 20+6

使用適応

Used in adults undergoing coronary angiography/PCI to identify patients at higher risk of post‑contrast AKI so preventive measures (hydration, contrast minimization, high‑dose statins) can be intensified. Applies to stable or ACS presentations; strongest predictors and validation come from PCI cohorts 1 [Level II evidence], with contemporary validation confirming risk discrimination 2 [Level II evidence]. Helps guide periprocedural strategy but not a substitute for clinical judgment.

洞察と注意事項

Identifies high-risk patients reasonably well but tends to overestimate absolute risk in contemporary PCI cohorts (external validations show C‑statistics ~0.61–0.68) 1 [Level II evidence].
Use cautiously in STEMI, hemodynamic instability, and high-contrast PCI, where risk is often underestimated.
Should not guide prophylaxis alone; hydration and minimizing contrast volume remain key 2 [Level I evidence].